Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-FR Version v19-EN
Language French English
Date Updated 2021-05-05 2021-05-05
Drug Identification Number 02414228 02414228
Brand name AURO-VALSARTAN AURO-VALSARTAN
Common or Proper name Valsartan Valsartan
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients VALSARTAN VALSARTAN
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100's & 500's 100's & 500's
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-07-31 2019-07-31
Estimated end date 2021-05-05 2021-05-05
Actual end date 2021-04-15 2021-04-15
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Auro-Valsartan 80 mg (100's) available Auro-Valsartan 80 mg (500's) replaceable with Auro-Valsartan 80 mg (100's) Auro-Valsartan 80 mg (100's) available Auro-Valsartan 80 mg (500's) replaceable with Auro-Valsartan 80 mg (100's)
Health Canada comments